DK1148065T3 - Fusionsproteiner omfattende to oplöselige gp130-molekyler - Google Patents

Fusionsproteiner omfattende to oplöselige gp130-molekyler

Info

Publication number
DK1148065T3
DK1148065T3 DK00108691T DK00108691T DK1148065T3 DK 1148065 T3 DK1148065 T3 DK 1148065T3 DK 00108691 T DK00108691 T DK 00108691T DK 00108691 T DK00108691 T DK 00108691T DK 1148065 T3 DK1148065 T3 DK 1148065T3
Authority
DK
Denmark
Prior art keywords
soluble
sgp130
molecules
fusion proteins
responses
Prior art date
Application number
DK00108691T
Other languages
Danish (da)
English (en)
Inventor
Stefan Rose-John
Original Assignee
Conaris Res Inst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conaris Res Inst Ag filed Critical Conaris Res Inst Ag
Application granted granted Critical
Publication of DK1148065T3 publication Critical patent/DK1148065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK00108691T 2000-04-21 2000-04-21 Fusionsproteiner omfattende to oplöselige gp130-molekyler DK1148065T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108691A EP1148065B1 (fr) 2000-04-21 2000-04-21 Protéines de fusion comprenant deux molécules gp130 solubles

Publications (1)

Publication Number Publication Date
DK1148065T3 true DK1148065T3 (da) 2008-04-28

Family

ID=8168532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00108691T DK1148065T3 (da) 2000-04-21 2000-04-21 Fusionsproteiner omfattende to oplöselige gp130-molekyler

Country Status (8)

Country Link
EP (1) EP1148065B1 (fr)
AT (1) ATE382636T1 (fr)
CY (1) CY1107380T1 (fr)
DE (1) DE60037648T2 (fr)
DK (1) DK1148065T3 (fr)
ES (1) ES2298106T3 (fr)
PT (1) PT1148065E (fr)
SI (1) SI1148065T1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
DE10321317A1 (de) * 2003-05-13 2004-12-23 Christian-Albrechts-Universität Zu Kiel Verfahren zum Nachweis des funktionellen IL-6/ sIL-6-Rezeptor-Komplexes und Test-Kit zur Durchführung dieses Verfahrens
EP1491554A1 (fr) * 2003-06-23 2004-12-29 CONARIS research institute AG Solubles gp130-dimeres modifiée avec du PEG pour utilisation comme medicament
ATE399868T1 (de) 2004-08-27 2008-07-15 Conaris Res Inst Ag Optimierte nukleotidsequenzen die für sgp130 kodieren
EP1801121A1 (fr) 2005-12-23 2007-06-27 CONARIS research institute AG Variantes solubles de la molécule gp130 utiles comme médicament
ES2352561T3 (es) * 2006-06-30 2011-02-21 Conaris Research Institute Ag Dímeros de sgp 130fc mejorados.
WO2009109584A1 (fr) * 2008-03-07 2009-09-11 Ferring International Center S. A. Anticorps qui ne se lie qu'au complexe il6-sil6r
TWI504609B (zh) * 2010-11-23 2015-10-21 Glaxo Group Ltd 抗原結合蛋白質
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
DK3227325T3 (da) 2014-12-01 2024-07-08 Ferring Bv Sammensætninger med selektive hæmmere af il-6-trans-signalering
HRP20210737T1 (hr) 2014-12-01 2021-06-11 Ferring B.V. Primjena selektivnog inhibitora il-6-trans-signalizacije
WO2020178193A1 (fr) 2019-03-01 2020-09-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthode de traitement de la sarcoïdose
WO2021250069A1 (fr) 2020-06-10 2021-12-16 Christian-Albrechts-Universität Zu Kiel Composé pharmaceutique pour le traitement d'une maladie cardiovasculaire athéroscléreuse
TW202242142A (zh) 2020-12-22 2022-11-01 荷蘭商菲林公司 預測炎性腸病患者的響應之血液基因表現生物標誌物
CN114681592A (zh) * 2020-12-31 2022-07-01 天境生物科技(杭州)有限公司 包含可溶性gp130二聚体的制剂和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262522A (en) * 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M

Also Published As

Publication number Publication date
ES2298106T3 (es) 2008-05-16
EP1148065B1 (fr) 2008-01-02
PT1148065E (pt) 2008-04-03
DE60037648D1 (de) 2008-02-14
ATE382636T1 (de) 2008-01-15
SI1148065T1 (sl) 2008-06-30
EP1148065A1 (fr) 2001-10-24
CY1107380T1 (el) 2012-12-19
DE60037648T2 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
CY1107380T1 (el) Πρωτεϊνες συντηξης που περιλαμβανουν δυο διαλυτα gp130 μορια
DK0510079T3 (da) Proteiner, der er produceret af humane lymfocytter, DNA-sekvenser, der koder for disse proteiner, og farmaceutiske og biolo
CA2236579A1 (fr) Procedes et compositions pour l'administration de proteines monomeres
DK0745094T3 (da) Superagonister og antagonister mod human IL-6 og fremgangsmåder til deres udvælgelse
ES2093623T3 (es) Receptores monovalentes y oligovalentes, bioespecificos y oligoespecificos, su preparacion y empleo.
DE50214416D1 (de) Vermehrung von viren in zellkultur
Putnam Abnormal human serum globulins
EP1191448A4 (fr) Systeme de collecte d'information
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
EP1403788A3 (fr) Elimination des opérations d'aggrégation "group-by" dans un plan de jointure
FI915279A0 (fi) Produktion av hemoglobin och derivat daerav i bakterier och jaest.
NO20025151L (no) Nye forbindelser
ATE466930T1 (de) Universelles sammelmedium
EA200300362A1 (ru) Способ генерирования молекулярно-функциональной сети
DE69519748D1 (de) Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
AR022890A1 (es) Citoquinas mamiferas; reactivos relacionados y metodos
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
ATE195116T1 (de) 4-chlor-1-(ethoxymethyl)-2-(p-chlorophenyl)-5- (trifluoromethyl)pyrrol-3-carbonitril und dessen verwendung als insektizid, nematozid und acarizid
ES2103595T3 (es) Determinacion de la concentracion de un gas.
BR9611947A (pt) Isoindolonas fundidas como inibidores da quinase da proteina c
EA200001134A1 (ru) Вакцина
DE60022879D1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
ATE451428T1 (de) Metallocenylphthalocyanine als optische aufzeichnungsmedien